CompuGroup Medical Acquires VISUS Health IT

CompuGroup Medical SECompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany.

VISUS's key products are JiveX Enterprise PACS, a leading PACS for hospitals and outpatient facilities, JiveX Healthcare Content Management, a cutting-edge vendor neutral archive solution for medical data, and JiveX Healthcare Connect with focus on communicating medical data. As a result of the acquisition, CompuGroup Medical is complementing its portfolio with a well-established and multiple award-winning product suite. For 2020, revenues were amounted to approximately EUR 18.5 million with an adjusted EBITDA of approximately EUR 2.8 million.

"VISUS complements our existing portfolio of products perfectly and we see a lot of opportunities to integrate these solutions with our successful ambulatory and hospital information systems," emphasized Dr. Dirk Wössner, CEO of CompuGroup Medical SE & Co. KGaA. "We are confident that both, existing CGM and VISUS customers, will benefit from this transaction, facilitating the provision of structured medical data at the right place and time and usable by anyone who needs it. VISUS solutions are a key contributor of medical information with the special focus on medical images."

"With this acquisition, we will gain an additional, highly attractive business area, which is very important for most of our customers, and we will significantly increase our installed customer base particularly in the German hospital market. At the same time, we will benefit from a great amount of know-how and expert knowledge from our new colleagues. We are acquiring innovative and strongly growing products here, which have recently been repeatedly honored with several highly prestigious 'Best in KLAS-Awards'," said Hannes Reichl, Managing Director Inpatient and Social Care at CGM.

"We are convinced that with this merger we will continue the success story of VISUS for our team and our customers in the long term. With CGM, we also have the potential to further expand our existing partner network internationally," said Klaus Kleber, Co-Founder of VISUS. Jörg Holstein, likewise Co-Founder of VISUS, added, "We have been partners with CGM for many years and have implemented many successful projects together. We are pleased to become part of the CGM family while maintaining the VISUS identity. CGM is exactly the right partner for us as a global player with home and heart in Germany."

VISUS's customer base today consists of more than 1.500 facilities inpatient as well as outpatient. Today, more than 1.6 million professional users, including doctors, dentists, pharmacies and other health professionals in outpatient and inpatient healthcare facilities trust CompuGroup Medical.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...